More expansion on the cards for Wrapsa

A capsule manufacturing machine at WrapsaWrapsa, one of South Africa’s biggest pharmaceutical contract manufacturing and packaging companies, has spent millions on continually upgrading its facilities. This is in line with the company’s policy to invest in infrastructure, ensuring accreditation and to retain its position in the local market.

Wrapsa was established in 1983 by Nardus Alberts, who made the strategic decision from outset to focus solely on third party manufacturing and not to produce in-house brands. He is also very serious about ploughing profit back into the company.

All eyes on new business

‘Since 2007 we have spent R80 million to upgrade our manufacturing plant and we are planning a second phase for 2017. Within the next 18 months, we want to extend Wrapsa’s manufacturing facilities to increase our tablet manufacturing ability in order to serve new clients,’ says Alberts.

Wrapsa’s aim is to give local brand owners a competitive edge. The exchange rate also makes local manufacturing a cost-effective and more flexible option for international clients.

With a variety of services and infrastructure developed to suit clients’ needs, Wrapa’s unique selling point is its ability to handle a variety of volumes. The principal staff members also have more than 100 years’ experience among them.

World-class services and solutions

Various high profile companies use Wrapsa for the manufacture of liquids, creams, ointments, gels, tablets, granules and tooth paste. The company also has an aerosol producing facility, which is among the top achieving aerosol producers in the Puregas Partnership Awards.

Wrapsa also offers specialised services that include the registration of medicine, validation assistance and the acceptance of raw materials and packaging components on consignment basis. On the packaging side, it offers blister and strip packaging, sachet filling, shrink wrapping, skin and blister packaging and packaging for tablets and capsules. The company also has a health supplement and packaging plant with ISO 22000:2005 accreditation.

‘We have the experience, ability and equipment to manufacture all kinds of pharmaceutical products and Wrapsa always complies with quality objectives, on time and without complaints. As we have so many high profile clients, our manufacturing standards are always under scrutiny and our plant is subjected to inspections by clients and the Medicines Control Council,’ says Alberts.

Wrapsa’s quality systems comply with the criteria set by the SABS for its ISO grading and is operated in line with required Good Manufacturing Practice.


Subscribe to our mailing list

* indicates required

Would you like to receive our FREE e-newsletter?

* indicates required
Close